AXGN:NASDAQ
AxoGen, Inc Common Stock
55,75 USD
arrow_downward
-1,06%(-0,60) 1 d.
56,10 USD
arrow_upward
+0,63% (+0,35)bedtimePo uzavretí
Zavreté: 20. 11., 16:00:02 GMT-5 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AXGN…
Otvoriť
55,71 USD
Vysoká
56,91 USD
Nízka
55,03 USD
Trh. kap.
3,33 mld.
Priem. obj.
1,86 mil.
Objem
876,00 tis.
Max. za 52 týž.
59,72 USD
Min. za 52 týž.
25,21 USD
Výnosy na akciu
-0,65 USD
Beta
1,21
Akcie v obehu
59,73 mil.
Počet zamestnancov
622
Otvoriť
55,71 USD
Vysoká
56,91 USD
Nízka
55,03 USD
Trh. kap.
3,33 mld.
Priem. obj.
1,86 mil.
Objem
876,00 tis.
Max. za 52 týž.
59,72 USD
Min. za 52 týž.
25,21 USD
Výnosy na akciu
-0,65 USD
Beta
1,21
Akcie v obehu
59,73 mil.
Počet zamestnancov
622
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
CNBC
·
pred 16 minútami
S&P 500 correction: Five forces behind the market sell-off
Forbes
·
pred 2 hodinami
S&P 500 Falls To 7-Month Low As Tech And AI Concerns Fuel Sell-Off
WSJ
·
pred 13 hodinami
S&P 500 Flirts With Correction
Los Angeles Times
·
pred 6 hodinami
S&P 500 falls 10% from record, entering correction as AI trade unravels
Profil
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
Informácie o subjekte AxoGen, Inc Common Stock
Generálny riaditeľ-
Zamestnanci622
Dátum založenia2002
Hlavné sídloAlachua, Florida, Spojené štáty americké
OdvetvieHealth Care
Odvetvie-